CompoAtlas

MELZ BEAUTE GLITTAGLOW CHEWABLE TABLET

MELZ BEAUTE GLITTAGLOW CHEWABLE TABLET : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
ASCORBIC ACID (VITAMIN C)ASCORBIC ACID (VITAMIN C)[212.5 mg,850 mg]Vitamine C
HAEMATOCOCCUS PLUVIALIS EXTRACTHAEMATOCOCCUS PLUVIALIS EXTRACT[25.5 mg,850 mg]Not identified
L-GLUTATHIONEL-GLUTATHIONE[25.5 mg,850 mg]Not identified
LYCOPERSICON ESCULENTUM (TOMATO)LYCOPERSICON ESCULENTUM (TOMATO)[42.5 mg,850 mg]Not identified
UBIQUINOLUBIQUINOL[8.5 mg,850 mg]Ubiquinol
L-CYSTEINE HCL MONOHYDRATEL-CYSTEINE HCL MONOHYDRATE[8.5 mg,850 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL22116052NC
Type
Health supplement
Published status
PRODUCT APPROVED
Licence holder
MELZ BEAUTE ENTERPRISE
Manufacturer
DZR PHARMA MANUFACTURE SDN. BHD.
Registration period starting
2022-11-22
Published validity end
2027-11-22

Original register data

View published fields and their variants
Active ingredients
ASCORBIC ACID (VITAMIN C)[212.5 mg,850 mg],HAEMATOCOCCUS PLUVIALIS EXTRACT[25.5 mg,850 mg],L-GLUTATHIONE[25.5 mg,850 mg],LYCOPERSICON ESCULENTUM (TOMATO)[42.5 mg,850 mg],UBIQUINOL[8.5 mg,850 mg],L-CYSTEINE HCL MONOHYDRATE[8.5 mg,850 mg]
Valid until
2027-11-22
Registration date
2022-11-22
Published description
HEALTH SUPPLEMENT
Licence holder
MELZ BEAUTE ENTERPRISE
Producer
DZR PHARMA MANUFACTURE SDN. BHD.
Published name
MELZ BEAUTE GLITTAGLOW CHEWABLE TABLET
Published reference
202208088454N
Registration number
MAL22116052NC
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL22116052NC

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • UBIQUINOL
    Read the warning, when it applies and the studies cited

    UBIQUINOL

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Langsjoen and Langsjoen 2008; Rosenfeldt et al. 2007; Engelsen et al. 2003; Singh et al. 1999; Landbo and Almdal 1998; Spigset 1994).

    Sources cited by Health Canada (6)
    • Engelsen J, Nielsen JD, Hansen KF. Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
    • Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
    • Langsjoen PH, Langsjoen AM. Supplemental ubiquinol in patients with advanced congestive heart failure. Biofactors 2008;32(1-4):119-128. PubMed Clinical trial
    • Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
    • Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial
    • Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report

    Applies to products providing more than 100 mg of Ubiquinol, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Langsjoen and Langsjoen 2008; Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).

    Sources cited by Health Canada (4)
    • Engelsen J, Nielsen JD, Hansen KF. Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
    • Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
    • Langsjoen PH, Langsjoen AM. Supplemental ubiquinol in patients with advanced congestive heart failure. Biofactors 2008;32(1-4):119-128. PubMed Clinical trial
    • Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report

    Condition of application: Migraine prophylaxis/prevention.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “MELZ BEAUTE GLITTAGLOW CHEWABLE TABLET”, https://compoatlas.com/en/supplements/malaysia/MAL22116052NC-melz-beaute-glittaglow-chewable-tablet, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line